1-3 of 3
Richard Bell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P004: Mapping the tumor-sentinel node immune migratome demonstrates a key role for CCR7+ dendritic cells in the successful response to immunoradiotherapy

Free
Robert Saddawi-Konefka, Riyam Al Msari, Shiqi Tang, Lauren M. Clubb, Santiago Fassardi, Riley Jones, Farhoud Faraji, Shiruyeh Schokrpur, Bryan S. Yung, Michael M. Allevato, Shawn M. Jensen, Bernard A. Fox, Richard Bell, J. Silvio Gutkind, Andrew Sharabi, Joseph A. Califano
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (2_Supplement): P004.
https://doi.org/10.1158/1557-3265.TARGETEDTHERAP-P004
Published: 26 January 2025
View articletitled, Abstract P004: Mapping the tumor-sentinel node immune migratome demonstrates a key role for CCR7+ dendritic cells in the successful response to immunoradiotherapy
Journal Articles

Bone-Related Complications and Quality of Life in Advanced Breast Cancer: Results from a Randomized Phase III Trial of Denosumab versus Zoledronic Acid

Free
Miguel Martin, Richard Bell, Hugues Bourgeois, Adam Brufsky, Ingo Diel, Alexandru Eniu, Lesley Fallowfield, Yasuhiro Fujiwara, Jacek Jassem, Alexander H.G. Paterson, Diana Ritchie, Günther G. Steger, Alison Stopeck, Charles Vogel, Michelle Fan, Qi Jiang, Karen Chung, Roger Dansey, Ada Braun
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (17): 4841–4849.
https://doi.org/10.1158/1078-0432.CCR-11-3310
Published: 30 August 2012
View articletitled, Bone-Related Complications and Quality of Life in Advanced Breast Cancer: Results from a Randomized Phase III Trial of Denosumab versus Zoledronic Acid
Open the PDF for Bone-Related Complications and Quality of Life in Advanced Breast Cancer: Results from a Randomized Phase III Trial of Denosumab versus Zoledronic Acid in another window
Journal Articles

A Multicenter Phase II Trial of Thalidomide and Celecoxib for Patients with Relapsed and Refractory Multiple Myeloma

Free
H Miles Prince, Linda Mileshkin, Andrew Roberts, Vinod Ganju, Craig Underhill, John Catalano, Richard Bell, John F. Seymour, David Westerman, Paul J. Simmons, Kate Lillie, Alvin D. Milner, Juliana Di Iulio, Jerome B. Zeldis, Robert Ramsay
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (15): 5504–5514.
https://doi.org/10.1158/1078-0432.CCR-05-0213
Published: 01 August 2005
View articletitled, A Multicenter Phase II Trial of Thalidomide and Celecoxib for Patients with Relapsed and Refractory Multiple Myeloma
Open the PDF for A Multicenter Phase II Trial of Thalidomide and Celecoxib for Patients with Relapsed and Refractory Multiple Myeloma in another window